Skip To Main Content
Deze website is alleen bedoeld voor zorgverleners van België en Luxemburg.
Campus
  • Wetenschap
  • Hulpmiddelen
Campus
  • Wetenschap
  • Hulpmiddelen
View Full Results

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

Efluelda® - Seizoensgebonden hooggedoseerd griepvaccin

Leer meer

Airway remodeling in asthma: Why targeting IL-4 and IL-13 matters

Leer meer

Reizigersziekten -Rabiës/Hondsdolheid

Leer meer

Reizigersziekten - Hepatitis A

Leer meer

Reizigersziekten

Leer meer

Reizigersziekten - Gele Koorts

Leer meer

Reizigersziekten - Buiktyfus

Leer meer

Beyfortus® ▼(nirsevimab): effectiveness and public health impact in the real world

Leer meer

Gaucher disease in children

Gaucher disease is an autosomal recessive lysosomal storage disorder caused by pathogenic variants in the GBA1 gene, resulting in deficient activity of the enzyme acid β glucosidase.

Leer meer

Real-World Evidence and Phase IV studies in CRSwNP

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.

Leer meer

DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP

The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3

Leer meer

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Leer meer